KAREN FOSBRINK: Open Payments
NPI 1558999748 · WADSWORTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 18 payments from 13 companies in 2025. Trend: 2023 $519 · 2024 $389 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $108 |
| Xeris Pharmaceuticals, Inc. | 1 | $83 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| ABBVIE INC. | 2 | $44 |
| Organon LLC | 2 | $44 |
| Ascensia Diabetes Care Us Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: BIJUVA, REXULTI, EPIDIOLEX, GVOKE HYPOPEN, TRELEGY ELLIPTA, UBRELVY, NEXPLANON, MOUNJARO.
Industry payments across OH — which companies pay providers there.
